# Reduced <i>NF1</i> Expression Confers Resistance to EGFR Inhibition in Lung Cancer

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/reduced-i-nf1-i-expression-confers-resistance-to-egfr-inhibition-in-lung-cancer/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Elza C. de Bruin,Catherine Cowell,Patricia H. Warne,Ming Jiang,Rebecca E. Saunders,Mary Ann Melnick,Scott Gettinger,Zenta Walther,Anna Wurtz,Guus J.J.E. Heynen,Daniëlle A.M. Heideman,Javier Gómez‐Román,Almudena García‐Castaño,Yixuan Gong,Marc Ladanyi,Harold Varmus,René Bernards,Egbert F. Smit,Katerina Politi,Julian Downward |
| Citations | 210 |
| DOI | 10.1158/2159-8290.cd-13-0741 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | green |
| OA URL | https://www.ncbi.nlm.nih.gov/pmc/articles/4011693 |
| OpenAlex ID | https://openalex.org/W2117784514 |
| PMID | 24535670 |
| Type | article |
| Year | 2014 |

## Paper authors

- [Marc Ladanyi](https://scholariq.org/researchers/marc-ladanyi/)
- [Javier Gómez‐Román](https://scholariq.org/researchers/javier-gomez-roman/)

## Paper journal

- [Cancer Discovery](https://scholariq.org/journals/cancer-discovery/)

## Paper primary topic

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Paper topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Melanoma and MAPK Pathways](https://scholariq.org/topics/melanoma-and-mapk-pathways/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.